Cargando…
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
A deeper understanding of early disease mechanisms occurring in Parkinson’s disease (PD) is needed to reveal restorative targets. Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy individuals or patients harboring LRRK2 PD-causing...
Autores principales: | Carola, G., Malagarriga, D., Calatayud, C., Pons-Espinal, M., Blasco-Agell, L., Richaud-Patin, Y., Fernandez-Carasa, I., Baruffi, V., Beltramone, S., Molina, E., Dell’Era, P., Toledo-Aral, J. J., Tolosa, E., Muotri, A. R., Garcia Ojalvo, J., Soriano, J., Raya, A., Consiglio, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253775/ https://www.ncbi.nlm.nih.gov/pubmed/34215735 http://dx.doi.org/10.1038/s41531-021-00198-3 |
Ejemplares similares
-
Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease
por: di Domenico, Angelique, et al.
Publicado: (2019) -
Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
por: Pons-Espinal, Meritxell, et al.
Publicado: (2020) -
Interplay of LRRK2 with chaperone-mediated autophagy
por: Orenstein, Samantha J., et al.
Publicado: (2013) -
Using iPS Cells toward the Understanding of Parkinson’s Disease
por: Torrent, Roger, et al.
Publicado: (2015) -
CRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons
por: Calatayud, Carles, et al.
Publicado: (2019)